Swedish Orphan Biovit Ord (BIOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BIOVF | GMAB | RGC | ||
| Company | Swedish Orphan Biovit Ord | Genmab A/S ADR | Regencell Bioscience Holdings Ltd | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 43.1500 | 26.03 | 28.70 | ||
| High | 43.1500 | 26.29 | 29.50 | ||
| Low | 43.1500 | 25.72 | 28.50 | ||
| Latest | 43.1500 | 26.11 | 28.95 | ||
| Change | +3.2799 | -0.68 | -0.10 | ||
| % Change | +8.23% | -2.54% | -0.34% | ||
| Volume | 100 | 1,837,600 | 63,900 | ||
| 20-Day Average Volume | 495 | 1,614,500 | 172,415 | ||
| Previous Close | 39.8701 | 26.79 | 29.05 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 33.0198 | 27.73 | 29.46 | ||
| 20-Day Raw Stochastic | 100.00% | 10.51% | 25.94% | ||
| 20-Day Relative Strength | 70.22 | 40.45 | 51.90 | ||
| Weighted Alpha | N/A | +10.55 | +42.05 | ||
| Today's Opinion | N/A | 64% Sell | 88% Buy | ||
| Previous Opinion | N/A | 64% Sell | 88% Buy | ||
| Last Month's Opinion | N/A | 72% Sell | 32% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +22.41% since 12/03/25 | -5.71% since 04/22/26 | -1.16% since 04/22/26 | ||
| Low | 36.5850 on 01/07/26 | 25.72 on 04/29/26 | 26.51 on 04/27/26 | ||
| High | 43.1500 on 04/27/26 | 27.57 on 04/23/26 | 30.00 on 04/28/26 | ||
| 1-Month | |||||
| %Chg | +4.43% since 03/04/26 | +1.12% since 03/27/26 | +12.78% since 03/27/26 | ||
| Low | 39.8701 on 03/31/26 | 25.72 on 04/29/26 | 23.03 on 03/30/26 | ||
| High | 43.1500 on 04/27/26 | 29.43 on 04/14/26 | 40.00 on 04/01/26 | ||
| 3-Month | |||||
| %Chg | +16.62% since 01/14/26 | -21.71% since 01/29/26 | +3.78% since 01/29/26 | ||
| Low | 39.8701 on 03/31/26 | 24.95 on 03/20/26 | 20.00 on 03/09/26 | ||
| High | 43.1500 on 04/27/26 | 33.52 on 02/03/26 | 40.00 on 04/01/26 | ||
| 6-Month | |||||
| %Chg | +29.58% since 10/06/25 | -9.81% since 10/29/25 | +74.29% since 10/29/25 | ||
| Low | 34.8800 on 11/04/25 | 24.95 on 03/20/26 | 10.33 on 11/25/25 | ||
| High | 43.1500 on 04/27/26 | 35.43 on 01/14/26 | 69.00 on 01/08/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 15,361,400 | 17,212,764 | 14,364,905 | ||
| Shares Outstanding, K | 356,000 | 642,507 | 494,489 | ||
| Annual Sales | 2,885,920,000 | 3,720,000,000 | 0 | ||
| Annual Net Income | 48,850,000 | 963,000,000 | -3,580,000 | ||
| Last Quarter Sales | 831,590,000 | 1,058,000,000 | N/A | ||
| Last Quarter Net Income | 197,880,000 | 31,000,000 | N/A | ||
| 60-Month Beta | 0.35 | 0.97 | 2.26 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.60 on 02/05/26 | 0.05 on 02/17/26 | N/A | ||
| Earnings Date | 05/05/26 | 05/14/26 | 01/30/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | 02/15/18 | ||
| Ratios | |||||
| Price/Earnings ttm | 22.91 | 17.19 | 0.00 | ||